3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
54.60
-0.50 (-0.91%)
Jul 4, 2025, 10:46 AM CST
38.23%
Market Cap 4.29B
Revenue (ttm) 265.69M
Net Income (ttm) 91.70M
Shares Out 77.84M
EPS (ttm) 1.30
PE Ratio 42.38
Forward PE n/a
Dividend 0.53 (0.96%)
Ex-Dividend Date n/a
Volume 5,211
Average Volume 345,727
Open 55.20
Previous Close 55.10
Day's Range 53.90 - 55.20
52-Week Range 33.70 - 73.50
Beta 0.42
RSI 41.01
Earnings Date Aug 8, 2025

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.